Cellectis SA (CLLS)
1.91
-0.07
(-3.54%)
USD |
NASDAQ |
Nov 14, 16:00
1.90
-0.01
(-0.52%)
After-Hours: 20:00
Cellectis Total Return Level: 1.91 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 1.91 |
November 13, 2024 | 1.98 |
November 12, 2024 | 1.975 |
November 11, 2024 | 1.91 |
November 08, 2024 | 1.77 |
November 07, 2024 | 1.75 |
November 06, 2024 | 1.77 |
November 05, 2024 | 1.78 |
November 04, 2024 | 1.76 |
November 01, 2024 | 1.80 |
October 31, 2024 | 1.78 |
October 30, 2024 | 1.82 |
October 29, 2024 | 1.83 |
October 28, 2024 | 1.93 |
October 25, 2024 | 1.86 |
October 24, 2024 | 1.90 |
October 23, 2024 | 1.97 |
October 22, 2024 | 1.80 |
October 21, 2024 | 1.835 |
October 18, 2024 | 1.90 |
October 17, 2024 | 1.91 |
October 16, 2024 | 1.90 |
October 15, 2024 | 1.89 |
October 14, 2024 | 1.95 |
October 11, 2024 | 2.01 |
Date | Value |
---|---|
October 10, 2024 | 2.00 |
October 09, 2024 | 1.95 |
October 08, 2024 | 1.96 |
October 07, 2024 | 1.97 |
October 04, 2024 | 1.894 |
October 03, 2024 | 1.98 |
October 02, 2024 | 1.96 |
October 01, 2024 | 2.02 |
September 30, 2024 | 2.12 |
September 27, 2024 | 2.184 |
September 26, 2024 | 2.19 |
September 25, 2024 | 2.16 |
September 24, 2024 | 2.21 |
September 23, 2024 | 2.20 |
September 20, 2024 | 2.257 |
September 19, 2024 | 2.32 |
September 18, 2024 | 2.28 |
September 17, 2024 | 2.34 |
September 16, 2024 | 2.30 |
September 13, 2024 | 2.25 |
September 12, 2024 | 2.40 |
September 11, 2024 | 2.307 |
September 10, 2024 | 2.22 |
September 09, 2024 | 2.255 |
September 06, 2024 | 2.24 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.97
Minimum
Oct 31 2023
33.25
Maximum
Jan 19 2021
8.744
Average
3.675
Median
Total Return Level Benchmarks
Genfit SA | 4.535 |
Edap TMS SA | 2.52 |
Adaptimmune Therapeutics PLC | 0.5912 |
NuCana PLC | 1.55 |
TC BioPharm (Holdings) PLC | 0.6488 |